English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Substance Abuse And Mental Health Services Administration
+
Community
Amanda Rupp
| Sep 4, 2016
Tennessee gains federal grants to stop opioid abuse
+
Community
Amanda Rupp
| Apr 21, 2016
FDA launches first campaign against smokeless tobacco
+
Regulatory
Amanda Rupp
| Apr 20, 2016
NAMI CEO releases statement on Labor-HHS-Education Subcommittee bill for 2017
+
Technology/Innovation
Amanda Rupp
| Mar 25, 2016
SAMHSA opens opioid recovery app challenge
Trending
+
Pharmaceuticals
Patient Daily
| Aug 4, 2026
Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+
Pharmaceuticals
Patient Daily
| Aug 6, 2026
FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+
Regulatory
M. R. Armstrong
| Aug 4, 2026
Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+
Pharmaceuticals
Patient Daily
| Aug 5, 2026
Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes
